South Korea's opposition parties condemned Yin Xiyue's office for preventing the police from searching.Vegetable oil rose by 2.08% on the 11th, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract vegetable oil closed at 2,505, up or down by +2.08%, with a turnover of 727,500 lots. The position data showed that the top 20 seats were net, and the difference position was 2,628 lots. The total turnover of vegetable oil futures contracts was 857,200 lots, an increase of 255,300 lots over the previous day. The first 20 seats in the contract held 240,200 lots, an increase of 6,901 lots over the previous day. The short positions in the top 20 seats of the contract were 239,200 lots, a decrease of 1,059 lots from the previous day. (Sina Futures)Shanghai Ailu: Signed the Strategic Cooperation Agreement with Huaneng New Energy. Shanghai Ailu (301062) announced on the evening of December 11th and signed the Strategic Cooperation Agreement with Huaneng New Energy: Huaneng New Energy will combine the technological research and development and industrial introduction advantages of the company and its holding subsidiary Aina New Energy, and conduct business transactions on the "glass fiber reinforced polyurethane composite frame" products independently developed by Aina New Energy, and through product procurement and technical exchange.
On the 11th, the 10-year treasury bond futures fell by 0.09%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract 10-year treasury bond futures closed at 2503, up or down by -0.09%, with a turnover of 65,600 lots. The position data showed that the top 20 seats were clear, and the difference position was 4,068 lots. The total number of 10-year treasury bond futures contracts was 69,300 lots, a decrease of 26,600 lots from the previous day. The first 20 seats in the contract held 176,000 lots, a decrease of 3,678 lots from the previous day. The short positions in the top 20 seats of the contract were 181,200 lots, a decrease of 713 lots from the previous day. (Sina Futures)Huize released its Q3 results in 2024, and the number of insured customers exceeded 10 million. On December 10th, HUIZ.US, an insurance e-commerce service platform, released its unaudited Q3 results report in the third quarter of 2024 (hereinafter referred to as "Q3") before the opening of the US stock market. The data shows that during Q3, Huixuan contributed a total premium of 2.06 billion yuan (RMB, the same below), a total revenue of 370 million yuan and a net profit of 18.7 million yuan. After experiencing rapid growth since the reform and opening up, China's economy is entering a new normal of medium-speed development. In 2024, opportunities and challenges coexist in the insurance industry. Q3 financial report data shows that Huixuan's accumulated insured customers have exceeded 10 million.Market News: The Ukrainian military said that the attack on the Russian oil depot triggered a "fire".
Hauser, Vice Chairman of the Reserve Bank of Australia: The direct impact of US tariffs on Australia may be limited. Hauser: Australia has a strong comparative advantage in raw materials and services. Flexible exchange rate and independent monetary policy are powerful shock absorbers. The Reserve Bank of Australia will respond in any direction to fulfill its responsibilities. The impact of (Trump policy) on inflation in Australia is ambiguous and may move in any direction. We will pay close attention to the progress of tariffs and stand ready to respond appropriately.Grant Thornton Group, a Hong Kong financial consulting and IPO sponsor service provider, is priced at $ 4-5 per share, and plans to raise $10 million.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.